Search

everythinglearnresearchcommunity

for

Search:↓

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Microparticles help caffeic acid stay longer in hair follicles for better treatment of folliculitis.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Using Excimer light with topical steroids is the most effective treatment for alopecia areata.

Squaric acid dibutylester led to complete hair regrowth in 28.5% of patients with alopecia areata.

Different hair loss treatment ingredients work well with TrichoTech™ vehicles for 3 to 6 months, making them good for use in hair treatments.

Avoiding damage and using specific shampoo and supplements improved the hair condition.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

New anti-acne medications are being tested to offer alternatives to current treatments.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

The treatment for alopecia areata with diphenylcyclopropenone was unsuccessful.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Pentoxifylline helps hair regrowth in rats with hair loss.

Liposomal adapalene improves delivery to hair follicles and reduces side effects for acne treatment.

The new delivery system improved hair growth in alopecia treatment.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

Diphenylcyclopropenone topical immunotherapy is effective for treating alopecia areata, with some side effects.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.